PHARMACEUTICAL COMPOSITION FOR ANTI-INFLAMMATION, OR PROMOTION OF BONE TISSUE FORMATION OR CARTILAGE TISSUE FORMATION, COMPRISING, AS AN ACTIVE INGREDIENT, STAUNTONIA HEXAPHYLLA LEAF-DERIVED EXTRACT OR FRACTIONAL PURIFIED PRODUCT OR NOVEL FLAVONOID COMPOUND AND CAFFEIC ACID COMPOUND SEPARATED THEREFROM

摘要

The present invention relates to a production method of a Stauntonia hexaphylla leaf-derived extract or a fractional purified product; a Stauntonia hexaphylla leaf-derived extract or a fractional purified product produced by the production method; and a pharmaceutical composition for anti-inflammation, or promotion of bone tissue formation or cartilage tissue formation, comprising, as an active ingredient, one or more selected from the group consisting of the Stauntonia hexaphylla leaf-derived extract or the fractional purified product, a caffeic acid compound and a novel flavonoid compound separated from the extract or the fractional purified product.